Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combidex Imaging in Brain Tumors and CNS Inflammation
NCT00659334Phase 2Terminated
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Aug 2000
- Primary completion
- Mar 2010
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of ferumoxtran-10 in brain neoplasm, stroke, multiple sclerosis (MS), sponsored by OHSU Knight Cancer Institute. Started Aug 2000; status: terminated.
02
Drugs
ferumoxtran-10
03
Conditions
brain neoplasmstrokemultiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00659334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00659334.